Clinical Trial Update: Special Investigation For Long-Term Use Of Sildenafil (Regulatory Post Marketing Commitment Plan)

View source ↗

Summary

A post-marketing commitment study update evaluating long-term use of sildenafil for pulmonary hypertension has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Pulmonary Hypertension | Status: COMPLETED | Results posted: 2017-04-24